|
|
|
|
|
|
|
|
|
21.01.26 - 02:33
|
Pakistan To Send Chinese Warplanes To Libyan Faction Under Gen. Haftar (ZeroHedge)
|
|
|
Pakistan To Send Chinese Warplanes To Libyan Faction Under Gen. Haftar
via Middle East Eye
Pakistan has sealed a deal worth over $4 billion to sell military equipment, including warplanes jointly built with China, to General Khalifa Haftar's Libyan National Army, according to a report by Reuters.
The deal could significantly alter the military balance of power in the oil-rich North African country, where Haftar rules over the eastern half and a UN-recognized government led by Prime Minister Abdul Hamid Dbeibeh in Tripoli controls the west.
Pakistan Air Force JF-17, via Military Watch Magazine
"Please make your armed forces as strong as possible because armed forces did guarantee the existence of countries," Pakistan military chief Field Marshal Asim Munir said in a visit to Benghazi last week, where he met Haftar's son, Saddam. Reuters reported that the arms deal was finalized in that meeting.
"Libya is a land of lions," Munir said in a video clip of his address to Lib...
|
|
|
21.01.26 - 02:18
|
China wants chips, US needs power: divergent AI growth paths emerge amid bubble concerns (SCMP)
|
|
|
China's government-led push into artificial intelligence (AI) contrasts with the US' private sector-led approach, with the world's two largest economies advancing along divergent paths, according to China International Capital Corp (CICC).
Chinese investments in AI had focused on underlying technologies, including advanced semiconductors, to address a shortage of computing resources resulting from the country's restricted access to advanced chips, the state-backed investment management firm said......
|
|
|
|
|
21.01.26 - 00:36
|
Harbour BioMed stake in US drug firm Spruce shows Chinese firms′ growing clout, analysts say (SCMP)
|
|
|
Shanghai-based Harbour BioMed's acquisition of a stake in US-based Spruce Biosciences is the latest example of China's novel drug developers progressing from one-time licensing deals into long-lasting equity partnerships with overseas partners.
The deal, detailed in a Hong Kong stock exchange filing on Monday, also showed Chinese firms' growing clout on the global pharmaceutical stage, analysts said.
“The coming years will see more Chinese biotech firms engaging in equity investments and joint......
|
|
|
|
|
|
|
20.01.26 - 22:12
|
Chinese Wok owner to take over Burger King operator (Times of India)
|
|
|
Inspira Global, owner of Chinese Wok, is acquiring Restaurant Brands Asia (RBA), the operator of Burger King India. This significant deal sees Everstone Capital exiting RBA with a Rs 460 crore stake sale. Inspira plans substantial capital infusion, aiming to bolster its presence in the fast-growing quick-service restaurant sector and expand its brand portfolio....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|